ConductScience.org, home

Paper29310082

Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.

Burmistrov V and 4 others. Bioorg Chem, 2018. Cited by 29 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability. Papers, record 29310082. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29310082

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.
PubMed
Journal
Bioorg Chem
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.55
iCite
Revised in PubMed
2019-02-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burmistrov VVladimir
2Morisseau CChristophe
3Harris TRTodd R
4Butov GGennady
5Hammock BDBruce D

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdamantaneMajor topic
Enzyme InhibitorsMajor topic
Epoxide HydrolasesMajor topic
UreaMajor topic
Animals
Catalytic Domain
Drug Stability
Enzyme Assays
Humans
Mice
Microsomes, Liver
Molecular Docking Simulation
Molecular Structure
Rats

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P42 ES004699NIEHS NIH HHSUnited StatesP42ES004699PubMed and NIHNIH RePORTER
R01 ES002710NIEHS NIH HHSUnited StatesR01ES002710PubMed and NIHNIH RePORTER

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,479,771Identification of potent inhibitors of the chicken soluble epoxide hydrolase.Bioorg Med Chem Lett2015https://conductscience.org/library/papers/25479771PubMed
215,963,942Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies.Anal Biochem2005https://conductscience.org/library/papers/15963942PubMed
316,157,792An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.Hypertension2005https://conductscience.org/library/papers/16157792PubMed
424,685,540Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.Bioorg Med Chem Lett2014https://conductscience.org/library/papers/24685540PubMed
511,090,543Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.Circ Res2000https://conductscience.org/library/papers/11090543PubMed
612,007,563Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.Biochem Pharmacol2002https://conductscience.org/library/papers/12007563PubMed
715,056,008Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.J Med Chem2004https://conductscience.org/library/papers/15056008PubMed
815,581,597Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.Arch Biochem Biophys2005https://conductscience.org/library/papers/15581597PubMed
920,664,072Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids.J Lipid Res2010https://conductscience.org/library/papers/20664072PubMed
1028,396,419Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28396419PubMed
1111,882,632Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.Hypertension2002https://conductscience.org/library/papers/11882632PubMed
1218,248,310Eicosanoids and renal damage in cardiometabolic syndrome.Expert Opin Drug Metab Toxicol2008https://conductscience.org/library/papers/18248310PubMed
1322,009,066EET signaling in cancer.Cancer Metastasis Rev2011https://conductscience.org/library/papers/22009066PubMed
144,584,115Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds.Xenobiotica1973https://conductscience.org/library/papers/4584115PubMed
1510,430,859Potent urea and carbamate inhibitors of soluble epoxide hydrolases.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10430859PubMed
168,307,189
Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins. Implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis.
FEBS Lett1994https://conductscience.org/library/papers/8307189PubMed
1723,045,145Measurement of soluble epoxide hydrolase (sEH) activity.Curr Protoc Toxicol2007https://conductscience.org/library/papers/23045145PubMed
1815,887,969Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.J Med Chem2005https://conductscience.org/library/papers/15887969PubMed
1917,616,115Orally bioavailable potent soluble epoxide hydrolase inhibitors.J Med Chem2007https://conductscience.org/library/papers/17616115PubMed
2015,994,227Soluble epoxide hydrolase is a therapeutic target for acute inflammation.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15994227PubMed

See all 29 references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
42,761,581Human breath as a carbon dioxide source for organic synthesis.RSC Adv2026https://conductscience.org/library/papers/42761581PubMed
40,573,730Indole Alkaloids and Phenolic Amides from the Rhizomes of Cimicifuga heracleifolia and Their In Vitro Soluble Epoxide Hydrolase (sEH) Inhibitory Activity.Plants (Basel)2025https://conductscience.org/library/papers/40573730PubMed
38,203,5101,3-Dichloroadamantyl-Containing Ureas as Potential Triple Inhibitors of Soluble Epoxide Hydrolase, p38 MAPK and c-Raf.Int J Mol Sci2023https://conductscience.org/library/papers/38203510PubMed
37,975,322Fluorine and chlorine substituted adamantyl-urea as molecular tools for inhibition of human soluble epoxide hydrolase with picomolar efficacy.J Enzyme Inhib Med Chem2023https://conductscience.org/library/papers/37975322PubMed
37,638,129Adamantyl-ureas with pyrazoles substituted by fluoroalkanes as soluble epoxide hydrolase inhibitors.J Fluor Chem2023https://conductscience.org/library/papers/37638129PubMed
37,601,415Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase.Results Chem2022https://conductscience.org/library/papers/37601415PubMed
37,110,811Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion.Molecules2023https://conductscience.org/library/papers/37110811PubMed
36,142,611Anti-Inflammatory Activity of Soluble Epoxide Hydrolase Inhibitors Based on Selenoureas Bearing an Adamantane Moiety.Int J Mol Sci2022https://conductscience.org/library/papers/36142611PubMed
35,271,276Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.J Med Chem2022https://conductscience.org/library/papers/35271276PubMed
33,945,278From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis.J Med Chem2021https://conductscience.org/library/papers/33945278PubMed
33,575,076Adamantane-linked isothiourea derivatives suppress the growth of experimental hepatocellular carcinoma via inhibition of TLR4-MyD88-NF-κB signaling.Am J Cancer Res2021https://conductscience.org/library/papers/33575076PubMed
33,369,424Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.J Med Chem2021https://conductscience.org/library/papers/33369424PubMed
33,101,030Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.Front Pharmacol2020https://conductscience.org/library/papers/33101030PubMed
33,007,552Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.Bioorg Med Chem2020https://conductscience.org/library/papers/33007552PubMed
32,824,969Polycarbonate/Sulfonamide Composites with Ultralow Contents of Halogen-Free Flame Retardant and Desirable Compatibility.Materials (Basel)2020https://conductscience.org/library/papers/32824969PubMed
32,736,212Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.Bioorg Med Chem Lett2020https://conductscience.org/library/papers/32736212PubMed
32,132,741Fluoroaromatic fragments on 1,3-disubstituted ureas enhance soluble epoxide hydrolase inhibition.J Fluor Chem2019https://conductscience.org/library/papers/32132741PubMed
32,032,849Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics.Bioorg Chem2020https://conductscience.org/library/papers/32032849PubMed
31,870,649Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.Bioorg Med Chem Lett2020https://conductscience.org/library/papers/31870649PubMed
31,488,357Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.Bioorg Med Chem2019https://conductscience.org/library/papers/31488357PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EPHX22,053PubTator's text mininghttps://conductscience.org/library/genes/2053NCBI Gene
SLTM79,811PubTator's text mininghttps://conductscience.org/library/genes/79811NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29310082

GET https://conductscience.org/api/papers/v1/29310082/references?page=2